This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Feb 1;199(3):390-392.

doi: 10.1164/rccm.201809-1776LE.

Reply to Lan and Shi: Different Background, Short Duration, and Inappropriate Participants May Harm Your Conclusion

Kenneth R Chapman¹, John R Hurst², Robert B Fogel³, Pascal Pfister⁴, Konstantinos Kostikas⁴, Jadwiga A Wedzicha^{5

6}

Affiliations

Affiliations

¹ 1 University of Toronto Toronto, Ontario, Canada.
² 2 University College London London, United Kingdom.
³ 3 Novartis Pharmaceuticals Corporation East Hanover, New Jersey.
⁴ 4 Novartis Pharma AG Basel, Switzerland.
⁵ 5 Imperial College London London, United Kingdom and.
⁶ 6 Editor-in-Chief, AJRCCM.

PMID: 30335471
DOI: 10.1164/rccm.201809-1776LE

Free article

Comment

Reply to Lan and Shi: Different Background, Short Duration, and Inappropriate Participants May Harm Your Conclusion

Kenneth R Chapman et al. Am J Respir Crit Care Med. 2019.

Free article

. 2019 Feb 1;199(3):390-392.

doi: 10.1164/rccm.201809-1776LE.

Authors

Kenneth R Chapman¹, John R Hurst², Robert B Fogel³, Pascal Pfister⁴, Konstantinos Kostikas⁴, Jadwiga A Wedzicha^{5

6}

Affiliations

¹ 1 University of Toronto Toronto, Ontario, Canada.
² 2 University College London London, United Kingdom.
³ 3 Novartis Pharmaceuticals Corporation East Hanover, New Jersey.
⁴ 4 Novartis Pharma AG Basel, Switzerland.
⁵ 5 Imperial College London London, United Kingdom and.
⁶ 6 Editor-in-Chief, AJRCCM.

PMID: 30335471
DOI: 10.1164/rccm.201809-1776LE

No abstract available

PubMed Disclaimer

Comment on

Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial.
Chapman KR, Hurst JR, Frent SM, Larbig M, Fogel R, Guerin T, Banerji D, Patalano F, Goyal P, Pfister P, Kostikas K, Wedzicha JA. Chapman KR, et al. Am J Respir Crit Care Med. 2018 Aug 1;198(3):329-339. doi: 10.1164/rccm.201803-0405OC. Am J Respir Crit Care Med. 2018. PMID: 29779416 Clinical Trial.
Different Background, Short Duration, and Inappropriate Participants May Harm Your Conclusion.
Lan G, Shi G. Lan G, et al. Am J Respir Crit Care Med. 2019 Feb 1;199(3):389-390. doi: 10.1164/rccm.201808-1439LE. Am J Respir Crit Care Med. 2019. PMID: 30335468 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information